Drug Type TCR-T Cell therapy |
Synonyms NW-101C |
Target |
Action inhibitors |
Mechanism PRAME inhibitors(PRAME nuclear receptor transcriptional regulator inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Clinical | China | - | |
Synovial Sarcoma | Clinical | China | - | |
Advanced Malignant Solid Neoplasm | IND Approval | China | 05 Aug 2025 |